相关实验视频

Updated: Jul 10, 2025

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells

Published on: June 9, 2020

调节SLFN11诱导DNA损伤反应的变化在乳腺癌中

Christophe Michel Raynaud¹, Eiman I Ahmed^2,3, Ayesha Jabeen²

¹Tumor Biology and Immunology Lab, Research Branch, Sidra Medicine, Doha, Qatar. raynaud.chris@gmail.com.

Cancer cell international

|November 24, 2023

概括

施莱芬家族成员11 (SLFN11) 的表达预测了对DNA损伤剂的反应. 这项研究表明,通过CRISPR-dCas9增加SLFN11可以提高乳腺癌对化疗的敏感性,从而提供一种新的治疗策略.

科学领域:

癌症生物学癌症生物学
基因组学就是基因组学.
分子治疗学分子治疗学

背景情况:

施莱芬家族成员11 (SLFN11) 表达是对各种癌症中对DNA损伤剂的反应的关键预测因子.
恢复SLFN11表达是一种克服耐火性癌症抵抗力的策略.
乳腺癌模型被用来探索增加SLFN11.11的方法.

研究的目的:

研究提高乳腺癌细胞中SLFN11表达的方法.
评估升高的SLFN11对化学敏感性的影响.
探索dCas9系统调节SLFN11表达和化学敏感性的潜力.

主要方法:

研究了达西 (一种去甲基化剂) 和IFN-γ对它们对SLFN11表达的影响.
采用SLFN11 dCas9系统 (UNISAM和KRAB) 进行SLFN11水平的特定和稳定的调制.
对DNA损伤剂 (例如,西斯,埃皮鲁比辛) 和DNA损伤反应抑制剂 (例如,Olaparib) 的化学敏感性评估变化.
利用RNA测序来了解SLFN11调制的基础机制.

主要成果:

德西塔和IFN-γ在BT-549和T47D细胞系中适度增加了SLFN11表达.
克里斯普尔-dCas9系统显著增加或减少SLFN11表达 (高达五倍),稳定和特定.
增加SLFN11表达增加了对DNA损伤剂和DDR抑制剂的敏感性.
在具有强大的促进物甲基化 (例如,MDA-MB-231) 的细胞系中没有观察到SLFN11诱导.

结论:

这项研究报告了在癌症细胞系中SLFN11表达的第一个稳定,非致命的增加.
提高SLFN11表达增加了对乳腺癌中化疗剂的敏感性.
克里斯普尔-dCas9系统为增加SLFN11提供了一种新的方法,有可能改善患者的治疗结果并减少药物剂量.
针对SLFN11的疗法需要进一步的临床前研究,以进行个性化癌症治疗.

关键词:

乳腺癌是什么? 乳腺癌是什么?化学敏感性化学敏感性西斯普拉丁 (Cisplatin) 是一种埃皮鲁比是一种类药物.龙是一种类动物.这就是Olaparib.在SLFN1111上.在UNISAM中,我们是UNISAM.

更多相关视频

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

Visualization of DNA Repair Proteins Interaction by Immunofluorescence

Visualization of DNA Repair Proteins Interaction by Immunofluorescence

Published on: June 26, 2020

相关概念视频

DNA Damage can Stall the Cell Cycle

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

The Intrinsic Apoptotic Pathway

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...

Epigenetic Regulation

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...